Please assess the completion status of the following clinical trial:

Trial Title: Assessing the Efficacy and Safety of DEXTENZA in Pseudo Phakic Patients Undergoing Gas Bubble Repair and Laser Following Retinal Detachment

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Pseudophakic~* Retinal Detachment~* Age 18 years and older~* Scheduled for gas bubble repair and laser surgery following retinal detachment~* Willing and able to comply with clinic visits and study related procedures~* Willing and able to sign the informed consent form~Exclusion Criteria:~* Patients under the age of 18.~* Pregnancy (must be ruled out in women of child-bearing age with pregnancy test)~* Active infectious systemic disease~* Active infectious ocular or extraocular disease~* Obstructed nasolacrimal duct in the study eye(s)~* Hypersensitivity to dexamethasone~* Patients being treated with immunomodulating agents in the study eye(s)~* Patients being treated with immunosuppressants and/or oral steroids~* Patients with severe disease that warrants critical attention, deemed unsafe for the study by the investigator

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Intracanalicular Sustained Release Dexamethasone, 0.4 mg (Type: EXPERIMENTAL): Intracanalicular dexamethasone insert contains 0.4 mg dexamethasone and is designed to provide a sustained and tapered release of therapeutic levels of dexamethasone to the ocular surface for up to 30 days for the reduction of post-surgical inflammation and pain associated with ocular surgery.
- topical prednisolone acetate 1%. (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).